Search research articles
Contact Us
Filters
Showing results (51-60 of 76) with videos related to
Page
of 8
Sort By:
Pharmaceutical Research
|
February 1, 1992
The influence of sucrose, dextran, and hydroxypropyl-beta-cyclodextrin as lyoprotectants for a freeze-dried mouse IgG2a monoclonal antibody (MN12)
M E Ressing, W Jiskoot, H Talsma, et al.
Cytotechnology
|
January 1, 1992
The potential of flow cytometric analysis for the characterization of hybridoma cells in suspension cultures
J M Coco-Martin, J W Oberink, T A van der Velden-de Groot, et al.
Infection and Immunity
|
November 1, 1986
Immunogenic activity of gonococcal protein I in mice with three different lipoidal adjuvants delivered in liposomes and in complexes
W Jiskoot, T Teerlink, M M Van Hoof, et al.
Developments in Biological Standardization
|
January 1, 1986
Analytical, toxicological and immunological consequences of the use of N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide as coupling reagent for the preparation of meningococcal group C polysaccharide-tetanus toxoid conjugate as vaccine for human use
E C Beuvery, G J Speijers, B I Lutz, et al.
European Journal of Biochemistry
|
October 1, 1991
Non-random conformation of a mouse IgG2a monoclonal antibody at low pH
W Jiskoot, M Bloemendal, B van Haeringen, et al.
Hybridoma
|
October 1, 1992
Instability of a hybridoma cell line in a homogeneous continuous perfusion culture system
J M Coco-Martin, J W Oberink, F Brunink, et al.
Journal of Biotechnology
|
December 20, 1999
Rational medium design for Bordetella pertussis: basic metabolism
M Thalen, J van den IJssel, W Jiskoot, et al.
Biotechnology and Bioengineering
|
February 20, 1993
Effect of dilution rate on growth, productivity, cell cycle and size, and shear sensitivity of a hybridoma cell in a continuous culture
D E Martens, C D de Gooijer, C A van der Velden-de Groot, et al.
Developments in Biological Standardization
|
January 1, 1986
Class 1/3 outer membrane protein vaccine against group B, type 15, subtype 16 meningococci
J T Poolman, E C Beuvery, C T Hopman, et al.
The Journal of Infectious Diseases
|
June 1, 1992
Preparation, antigenicity, and immunogenicity of synthetic ribosylribitol phosphate oligomer-protein conjugates and their potential use for vaccination against Haemophilus influenzae type b disease
D Evenberg, P Hoogerhout, C A van Boeckel, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 76) with videos related to
Sort By:
Page
of 8
Pharmaceutical Research
|
February 1, 1992
The influence of sucrose, dextran, and hydroxypropyl-beta-cyclodextrin as lyoprotectants for a freeze-dried mouse IgG2a monoclonal antibody (MN12)
M E Ressing, W Jiskoot, H Talsma, et al.
Cytotechnology
|
January 1, 1992
The potential of flow cytometric analysis for the characterization of hybridoma cells in suspension cultures
J M Coco-Martin, J W Oberink, T A van der Velden-de Groot, et al.
Infection and Immunity
|
November 1, 1986
Immunogenic activity of gonococcal protein I in mice with three different lipoidal adjuvants delivered in liposomes and in complexes
W Jiskoot, T Teerlink, M M Van Hoof, et al.
Developments in Biological Standardization
|
January 1, 1986
Analytical, toxicological and immunological consequences of the use of N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide as coupling reagent for the preparation of meningococcal group C polysaccharide-tetanus toxoid conjugate as vaccine for human use
E C Beuvery, G J Speijers, B I Lutz, et al.
European Journal of Biochemistry
|
October 1, 1991
Non-random conformation of a mouse IgG2a monoclonal antibody at low pH
W Jiskoot, M Bloemendal, B van Haeringen, et al.
Hybridoma
|
October 1, 1992
Instability of a hybridoma cell line in a homogeneous continuous perfusion culture system
J M Coco-Martin, J W Oberink, F Brunink, et al.
Journal of Biotechnology
|
December 20, 1999
Rational medium design for Bordetella pertussis: basic metabolism
M Thalen, J van den IJssel, W Jiskoot, et al.
Biotechnology and Bioengineering
|
February 20, 1993
Effect of dilution rate on growth, productivity, cell cycle and size, and shear sensitivity of a hybridoma cell in a continuous culture
D E Martens, C D de Gooijer, C A van der Velden-de Groot, et al.
Developments in Biological Standardization
|
January 1, 1986
Class 1/3 outer membrane protein vaccine against group B, type 15, subtype 16 meningococci
J T Poolman, E C Beuvery, C T Hopman, et al.
The Journal of Infectious Diseases
|
June 1, 1992
Preparation, antigenicity, and immunogenicity of synthetic ribosylribitol phosphate oligomer-protein conjugates and their potential use for vaccination against Haemophilus influenzae type b disease
D Evenberg, P Hoogerhout, C A van Boeckel, et al.
Page
of 8